1-5 of 5
Myla Strawderman
Close
Sort by
Journal Articles

Therapeutic Modulation of the Marrow Microenvironment in MDS: A Phase I Trial of Abaloparatide and Bevacizumab

Jozal W. Moore, Jason H. Mendler, Kah Poh (melissa) Loh, Mitra Azadniv, Kristen M. O'Dwyer, Eric J. Huselton, Frank Akwaa, Benjamin J. Frisch, Myla Strawderman, Mark W. LaMere, Daniel K. Byun, Alyssa C. Jasper, Michael W. Becker, Jane L. Liesveld, Laura M. Calvi
Journal: Blood
Blood (2022) 140 (Supplement 1): 4050–4052.
https://doi.org/10.1182/blood-2022-159515
Published: 2022
Journal Articles

Using Real World Data (RWD) to Identify Care Needs in an Adolescent and Young Adult (AYA) Lymphoma Population: A Match Cohort Study

John L Mariano, Myla Strawderman, Eric Snyder, Carla Casulo
Journal: Blood
Blood (2021) 138 (Supplement 1): 3053.
https://doi.org/10.1182/blood-2021-154208
Published: 2021
Journal Articles

Describing Treatment of Primary Mediastinal Large B Cell Lymphoma Using Rigorously Defined Molecular Classification: A Retrospective Analysis

Carla Casulo, MD, Myla Strawderman, MS, Raphael Steiner, MD, Carolyne Delage, MD, Tina Faugh, Matthew J. Maurer, MS, Brian K. Link, MD, Allison C. Rosenthal, D.O., Colleen Ramsower, B.S. M.B., Richard Burack, MD PhD, Sergei Syrbu, MD PhD, Andrew L. Feldman, MD, Philip J Rock, James R. Cerhan, MD PhD, Christopher Flowers, MDMS, Lisa M. Rimsza, MD, Jonathan W. Friedberg, MD MSSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-143171
Published: 2020
Journal Articles

A Novel Method for Identifying Transgender and Gender Diverse Patients with Lymphoma: A Single Center Experience

Alison B Alpert, MD MFA, Shea A Nagle, Manuel J Greer, Philip J Meacham, MS, Peter Macdowell, MS, Nicholas Gerbino, Myla Strawderman, MS, Kyle Trenshaw, PhD, Tina Faugh, Carla Casulo
Journal: Blood
Blood (2019) 134 (Supplement_1): 5825.
https://doi.org/10.1182/blood-2019-126884
Published: 2019
Journal Articles

Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival in Patients with Low Tumor Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab

Jonathan W. Friedberg, MD, Michael T. Brady, PhD, Myla Strawderman, MS, Brad S. Kahl, MD, John P. Leonard, MD, Izidore S. Lossos, MD, Christopher R. Flowers, MD MS, Grerk Sutamtewagul, MD, Jonathon B. Cohen, MDMS, Derick R. Peterson, PhD, Loretta J. Nastoupil, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 4008.
https://doi.org/10.1182/blood-2019-127320
Published: 2019